EP Patent

EP2819674A2 — Compositions and methods for the treatment of migraine

Assigned to Eye Therapies LLC · Expires 2015-01-07 · 11y expired

What this patent protects

Pharmaceutical compositions for the treatment of nasal congestion or migraine, wherein the pharmaceutical compositions comprise low concentrations of a super-selective subclass of selective α-2 adrenergic receptor agonists.

USPTO Abstract

Pharmaceutical compositions for the treatment of nasal congestion or migraine, wherein the pharmaceutical compositions comprise low concentrations of a super-selective subclass of selective α-2 adrenergic receptor agonists.

Drugs covered by this patent

Patent Metadata

Patent number
EP2819674A2
Jurisdiction
EP
Classification
—
Expires
2015-01-07
Drug substance claim
No
Drug product claim
No
Assignee
Eye Therapies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.